RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 31, 16:00
RVL Pharmaceuticals Free Cash Flow: -47.48M for June 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2023 | -47.48M |
| March 31, 2023 | -32.38M |
| December 31, 2022 | -38.56M |
| September 30, 2022 | -45.95M |
| June 30, 2022 | -52.02M |
| March 31, 2022 | -57.91M |
| December 31, 2021 | -56.51M |
| September 30, 2021 | -40.96M |
| June 30, 2021 | -15.92M |
| March 31, 2021 | 3.562M |
| Date | Value |
|---|---|
| December 31, 2020 | 14.46M |
| September 30, 2020 | 23.13M |
| June 30, 2020 | 50.35M |
| March 31, 2020 | 35.28M |
| December 31, 2019 | 29.53M |
| September 30, 2019 | 59.05M |
| June 30, 2019 | 29.40M |
| March 31, 2019 | 20.99M |
| December 31, 2018 | 33.41M |
Free Cash Flow Range, Past 5 Years
-57.91M
Minimum
Mar 2022
59.05M
Maximum
Sep 2019
-8.408M
Average
-15.92M
Median
Jun 2021
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.06M |
| Cash from Investing (Quarterly) | -0.959M |
| Cash from Financing (Quarterly) | -0.46M |
| Free Cash Flow Per Share (Quarterly) | -0.1319 |
| Free Cash Flow to Equity (Quarterly) | -13.67M |
| Free Cash Flow to Firm (Quarterly) | -9.966M |